Financial writer advises caution on Jyong Biotech Ltd. IPO due to high debt, legal issues, and FDA challenges. Click for my ...

The aggregate gross proceeds to the Company from the offering are expected to be approximately $1.05 million, before ...

Viracta, a California biotech oncology firm, is laying off every remaining employee and shutting down after its cash stores ...

Oxford Cannabinoid Technologies is shedding its old skin. Having delisted its stock last year, the biotech is rebranding as ...

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

National Testing Agency (NTA) has invited Online Applications for Graduate Aptitude Test- Biotechnology (GAT-B) – 2025, a ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

After an apparent accidental early release, Pfizer has revealed phase 1 data showing its investigational candidate, alongside ...

For example, Brittany found that drugs being developed by Generate were modified versions of existing antibodies, and that ...

The fund aims to build a portfolio of 20-25 companies that address gaps in services and products across pharmaceuticals, ...

The MAD cohort also saw adverse events such as hair loss and reductions in hemoglobin and neutrophil counts. These side ...

Vetigenics is seeing encouraging results of a completed study for an antibody aimed at treating oral melanoma in dogs, used ...